Month: January 2022

 January 26th 2022   CoinShares Digital Securities Limited CoinShares Physical Staked Tezos CoinShares Physical Staked Polkadot   Sharing of Staking Rewards CoinShares Digital Securities Limited (the “Issuer”) hereby announces in accordance with Condition 5.3.2 of the Conditions of the CoinShares Digital Securities that Staking Rewards in relation to the class (the “Specified Class”) specified below will be applied by a reduction in the Management Fee applicable to the Specified Class to zero and a positive daily accrual to the Coin Entitlement to the Specified Class provided in the table below .  Such reduction to the Management Fee and positive daily accrual to the Coin Entitlement shall apply from the start of trading on January 26th, 2022 until a date to be specified in a further announcement in accordance with Condition 5.3.2....

Bollène, January 26, 2022 – 07 :00 am (CET)Press Release 2021 Revenue Despite the continued difficulties resulting from the Covid pandemic, the Egide Group has continued resiliency providing growth in 2021.Turnover 2021: €32.5 million (+ 8.6%)Egide SA confirmed its profitable growth trajectory with turnover increase by 5.8%. Egide USA has recovered from the industrial fire and despite delays in delivery of its new plating shop, has turnover growth of 27.0% in 2021, lower than expected due to key labor shortages of technical workforce. Santier had a slight decline in turnover (-1.1% in $) in 2021.OutlookYearly “book to bill” ratio is essentially 1.0 with order entry acceleration in Q4 21: over 37% of order intake occurred in Q4. An order book of €22 million, which does not include additions for gold plating €1 million....

Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and CanadaIdorsia to capitalize upon the unique opportunity to transform the insomnia treatment paradigm, notably in Europe where daridorexant would be the first dual orexin receptor antagonist made available to patients with insomnia Collaboration with Syneos Health to effectively reach the primary care market in Europe and CanadaAllschwil, Switzerland & Morrisville, N.C. – January 26, 2022Idorsia Ltd (SIX: IDIA), a leading Swiss biopharmaceutical company, and Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the treatment of insomnia across Europe and...

NEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) — Full House Resorts, Inc. (“Full House” or the “Company”) (Nasdaq: FLL) announced today that it has commenced a solicitation (the “Solicitation”) of consents (the “Consents”) to amend the Indenture (such amendments, the “Amendments”) dated as of February 12, 2021 (as amended or supplemented through the date hereof, the “Indenture”) governing Full House’s 8.250% Senior Secured Notes due 2028 (the “Notes”) (CUSIP Nos. 359678 AC3 and U3232F AB3) to allow for the incurrence of up to $100.0 million of additional Notes (the “Additional Notes”) (i) to develop, equip and open The Temporary by American Place, our planned temporary casino in Waukegan, Illinois (“The Temporary”) which we intend to operate while we design and construct our permanent American Place facility, (ii) to pay the transaction...

ATLANTA, Jan. 25, 2022 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its first quarter ended December 31, 2021, after U.S. markets close on Thursday, February 3, 2022. On Friday, February 4, 2022, at 9:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call. About Mueller Water Products, Inc. Mueller Water Products, Inc. is a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America.  Our broad product and service portfolio...

VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Brascan Gold Inc. (CSE: BRAS) (“Brascan” or the “Company“) is pleased to announce that its common shares have commenced trading on the Frankfurt Exchange under the symbol “5ZT” (the “Listing“). A listing on the Frankfurt Exchange provides companies with access to millions of international investors. The Frankfurt Exchange ranks third in terms of volume of shares traded, behind the New York Stock Exchange and the NASDAQ. The Frankfurt Exchange is the twelfth largest exchange in the world and the largest in Europe by market capitalization. A copy of the Company’s Prospectus is available under the Company’s profile at www.SEDAR.com. The Company is also announcing that Mr. Permjeet Chattu, Vice President, Brascan Gold, is resigning from his position. Balbir Johal, Director...

Figure 1Location of the Alegre Gold ProjectFigure 2Location of the Alegre Gold Project property (yellow) between Goldmining’s Cachoeira Gold Project (green) to the north, and OZ Minerals’ CentroGold Project to the south, within the same structurally deformed volcaniclastic stratigraphic unit.Figure 3Gold garimpo of significant scale on the Alegre property.VANCOUVER, British Columbia., Jan. 25, 2022 (GLOBE NEWSWIRE) — Brascan Gold Inc. (CSE: BRAS) (“Brascan” or the “Company”) is pleased to announce formal activation of the Alegre Gold Project (the “Project”) earn-in option agreement in Pará State in northeastern Brazil. Brascan can now begin exploration of the highly prospective Alegre Gold Property. Location of the Alegre Gold Project:https://www.globenewswire.com/NewsRoom/AttachmentNg/876f6161-d3d5-4399-bd31-61b59e154469 Brascan...

BERKELEY, Calif. and MAINZ, Germany, Jan. 26, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the pricing of its underwritten public follow-on offering (the “Follow-on Offering”) of 1,500,000 ordinary shares at a public offering price of US$15.00 per ordinary share (the “Offering Price”), for gross proceeds of $22,500,000. The Follow-on Offering is being made pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”). The Follow-on Offering is expected to close on January 28, 2022, subject to the satisfaction of customary closing conditions. In connection with the Follow-on Offering, Mainz Biomed has granted the underwriter the option...

QUINCY, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) — Randolph Bancorp, Inc. (NASDAQ: RNDB) Randolph Bancorp, Inc. (the “Company”) (NASDAQ Global Market: RNDB), the holding company for Envision Bank (the “Bank”), today announced net income of $786,000, or $0.17 per basic share and $0.16 per diluted share, for the three months ended December 31, 2021 compared to net income of $3.1 million, or $0.64 per basic and $0.62 per diluted share, for the three months ended September 30, 2021 and net income of $5.3 million, or $1.03 per basic share and $1.01 per diluted share, for the three months ended December 31, 2020. Excluding one-time events of $26,000 in severance expenses and $55,000 in loss of disposal of fixed assets, net income on a non-GAAP basis was $844,000, or $0.17 per diluted share, for the three months ended December 31, 2021....

QUAKERTOWN, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) — QNB Corp. (the “Company” or “QNB”) (OTC Bulletin Board: QNBC), the parent company of QNB Bank (the “Bank”), reported net income for the fourth quarter of 2021 of $4,149,000, or $1.17 per share on a diluted basis. This compares to net income of $4,151,000, or $1.17 per share on a diluted basis, for the same period in 2020. For the year ended December 31, 2021, QNB reported net income of $16,492,000, or $4.64 per share on a diluted basis. This compares to net income of $12,083,000, or $3.42 per share on a diluted basis, reported for the same period in 2020. For the quarter ended December 31, 2021, the annualized rate of return on average assets and average shareholders’ equity was 0.98% and 11.82%, respectively, compared with 1.16% and 12.95%, respectively, for the fourth quarter...